A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects

NCT02753218 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Due to tolerability issues related to the dose titration, unexpected withdrawals were observed and it was unlikely for the trial to meet its objectives

Conditions

Interventions

Sponsor

LEO Pharma